Twist1‑mediated Transcriptional Activation of Claudin‑4 Promotes Cervical Cancer Cell Migration and Invasion

Overview

Journal Oncol Lett

Specialty Oncology

Date 2023 Jul 10

PMID 37427351

Authors

Jiaqi Zhu

Qi Jiang

Affiliations

Soon will be listed here.

Abstract

Claudin-4, a member of the claudin multigene family, participates in events associated with mesenchymal-like activity of cancerous cells. Claudin-4 expression is upregulated in cervical cancer tissue compared with that in adjoining non-neoplastic tissue. However, the mechanisms that regulate Claudin-4 expression in cervical cancer are poorly understood. Moreover, whether Claudin-4 contributes to the migration and invasion of cervical cancer cells remains unclear. By western blotting, reverse transcription-qPCR, bioinformatics analysis, dual-luciferase reporter assay, chromatin immunoprecipitation assay, wound healing assay and Transwell migration/invasion assay, the present study confirmed that Claudin-4 was a downstream target of Twist1, a helix-loop-helix transcriptional factor, the activity of which has a positive correlation with Claudin-4 expression. Mechanistically, Twist1 directly binds to Claudin-4 promoter, resulting in the transactivation of expression. The depletion of the Twist1-binding E-Box1 domain on Claudin-4 promoter via CRISPR-Cas9 knockout system downregulates Claudin-4 expression and suppresses the ability of cervical cancer cells to migrate and invade by elevating E-cadherin levels and lowering N-cadherin levels. Following activation by transforming growth factor-β, Twist1 induces Claudin-4 expression, thus enhancing migration and invasion of cervical cancer cells. In summary, the present data suggested that Claudin-4 was a direct downstream target of Twist1 and served a critical role in promoting Twist1-mediated cervical cancer cell migration and invasion.

Citing Articles

Fibroblasts regulate the transcriptional signature of human papillomavirus-positive keratinocytes.

James C, Lewis R, Witt A, Carter C, Rais N, Wang X Tumour Virus Res. 2024; 19:200302.

PMID: 39667669 PMC: 11699615. DOI: 10.1016/j.tvr.2024.200302.

Fibroblasts Regulate the Transformation Potential of Human Papillomavirus-positive Keratinocytes.

James C, Lewis R, Witt A, Carter C, Rais N, Wang X bioRxiv. 2024; .

PMID: 39345623 PMC: 11430071. DOI: 10.1101/2024.09.16.613347.

Claudins in Cancer: A Current and Future Therapeutic Target.

Hana C, Thaw Dar N, Galo Venegas M, Vulfovich M Int J Mol Sci. 2024; 25(9).

PMID: 38731853 PMC: 11083183. DOI: 10.3390/ijms25094634.

Aberrant Expression of Claudins in Head and Neck Carcinomas and Their Prognostic and Therapeutic Value: A Narrative Review.

Arabi T, Algheryafi L, Alodah N, Enabi H, Alshehry A, Ouban A Cancers (Basel). 2023; 15(17).

PMID: 37686483 PMC: 10486703. DOI: 10.3390/cancers15174208.

Natural Products Treat Colorectal Cancer by Regulating miRNA.

Guo S, Chen M, Li S, Geng Z, Jin Y, Liu D Pharmaceuticals (Basel). 2023; 16(8).

PMID: 37631037 PMC: 10459054. DOI: 10.3390/ph16081122.

References

Leotlela P, Wade M, Duray P, Rhode M, Brown H, Rosenthal D . Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene. 2006; 26(26):3846-56. DOI: 10.1038/sj.onc.1210155. View

Chen C, Shen N, Chen Y, Jiang P, Sun W, Wang Q . LncCCLM inhibits lymphatic metastasis of cervical cancer by promoting STAU1-mediated IGF-1 mRNA degradation. Cancer Lett. 2021; 518:169-179. DOI: 10.1016/j.canlet.2021.07.005. View

Yoon C, Kim M, Park M, Park I, Hwang S, An S . Claudin-1 acts through c-Abl-protein kinase Cdelta (PKCdelta) signaling and has a causal role in the acquisition of invasive capacity in human liver cells. J Biol Chem. 2009; 285(1):226-33. PMC: 2804169. DOI: 10.1074/jbc.M109.054189. View

Agarwal R, DSouza T, Morin P . Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res. 2005; 65(16):7378-85. DOI: 10.1158/0008-5472.CAN-05-1036. View

Yeeravalli R, Kaushik K, Das A . TWIST1-mediated transcriptional activation of PDGFRβ in breast cancer stem cells promotes tumorigenesis and metastasis. Biochim Biophys Acta Mol Basis Dis. 2021; 1867(7):166141. DOI: 10.1016/j.bbadis.2021.166141. View

Zhang Y, Alexander P, Wang X . TGF-β Family Signaling in the Control of Cell Proliferation and Survival. Cold Spring Harb Perspect Biol. 2016; 9(4). PMC: 5378054. DOI: 10.1101/cshperspect.a022145. View

Hwang T, Lee L, Wang C, Liang Y, Huang S, Wu C . Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer. Exp Ther Med. 2012; 1(5):789-797. PMC: 3445934. DOI: 10.3892/etm.2010.116. View

Ribatti D, Tamma R, Annese T . Epithelial-Mesenchymal Transition in Cancer: A Historical Overview. Transl Oncol. 2020; 13(6):100773. PMC: 7182759. DOI: 10.1016/j.tranon.2020.100773. View

Stelzle D, Tanaka L, Lee K, Ibrahim Khalil A, Baussano I, Shah A . Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2020; 9(2):e161-e169. PMC: 7815633. DOI: 10.1016/S2214-109X(20)30459-9. View

10.

Zhang S, Xu H, Zhang L, Qiao Y . Cervical cancer: Epidemiology, risk factors and screening. Chin J Cancer Res. 2021; 32(6):720-728. PMC: 7797226. DOI: 10.21147/j.issn.1000-9604.2020.06.05. View

11.

Michl P, Barth C, Buchholz M, Lerch M, Rolke M, Holzmann K . Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res. 2003; 63(19):6265-71. View

12.

Neesse A, Griesmann H, Gress T, Michl P . Claudin-4 as therapeutic target in cancer. Arch Biochem Biophys. 2012; 524(1):64-70. DOI: 10.1016/j.abb.2012.01.009. View

13.

Park S, Kim M, Lee S, Jung W, Kim B . Therapeutic Potential of Natural Products in Treatment of Cervical Cancer: A Review. Nutrients. 2021; 13(1). PMC: 7824868. DOI: 10.3390/nu13010154. View

14.

Wei X, Wei Z, Li Y, Tan Z, Lin C . AKR1C1 Contributes to Cervical Cancer Progression via Regulating TWIST1 Expression. Biochem Genet. 2020; 59(2):516-530. DOI: 10.1007/s10528-020-10014-x. View

15.

Meng J, Chen S, Han J, Qian B, Wang X, Zhong W . Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma. Cancer Res. 2018; 78(15):4150-4162. DOI: 10.1158/0008-5472.CAN-17-3009. View

16.

Shu J, Wang X, Yang X, Zhao G . ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms. Sci Rep. 2023; 13(1):882. PMC: 9845372. DOI: 10.1038/s41598-023-28185-z. View

17.

Sonoki H, Sato T, Endo S, Matsunaga T, Yamaguchi M, Yamazaki Y . Quercetin Decreases Claudin-2 Expression Mediated by Up-Regulation of microRNA miR-16 in Lung Adenocarcinoma A549 Cells. Nutrients. 2015; 7(6):4578-92. PMC: 4488803. DOI: 10.3390/nu7064578. View

18.

Suzuki M, Kato-Nakano M, Kawamoto S, Furuya A, Abe Y, Misaka H . Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers. Cancer Sci. 2009; 100(9):1623-30. PMC: 11159503. DOI: 10.1111/j.1349-7006.2009.01239.x. View

19.

Zheng Y, Dai M, Dong Y, Yu H, Liu T, Feng X . ZEB2/TWIST1/PRMT5/NuRD Multicomplex Contributes to the Epigenetic Regulation of EMT and Metastasis in Colorectal Carcinoma. Cancers (Basel). 2022; 14(14). PMC: 9324012. DOI: 10.3390/cancers14143426. View

20.

Vu M, Yu J, Awolude O, Chuang L . Cervical cancer worldwide. Curr Probl Cancer. 2018; 42(5):457-465. DOI: 10.1016/j.currproblcancer.2018.06.003. View